Estimated Cancer Incidence in Brazil, 2023-2025
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng spa |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/3700 |
Resumo: | Introduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries. |
id |
INCA-1_c7209da035748cc65cc40fe654d4305c |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/3700 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Estimated Cancer Incidence in Brazil, 2023-2025Incidencia Estimada de Cáncer en Brasil, 2023-2025Estimativa de Incidência de Câncer no Brasil, 2023-2025neoplasias/epidemiologianeoplasias/mortalidadeincidênciaestatísticaBrasilneoplasms/epidemiologyneoplasms/mortalityincidencestatisticsBrazilneoplasias/epidemiologíaneoplasias/mortalidadincidenciaestadísticaBrasilIntroduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries.Introducción: El cáncer es un problema de salud pública mundial, en la última década, hubo un incremento de un 20% en la incidencia y se espera, para 2030, más de 25 millones de nuevos casos. Estimaciones del número de nuevos casos de cáncer son una herramienta poderosa para fundamentar políticas públicas y la asignación racional de recursos para el combate contra el cáncer. La vigilancia es un elemento crucial para la planificación, monitoreo y evaluación de las acciones de control del cáncer. Objetivo: Estimar y describir la incidencia de cáncer en el país, regiones geográficas, Unidades de la Federación, Distrito Federal y capitales, por género, para el trienio 2023-2025. Método: Las informaciones fueron extraídas del Sistema de Información sobre Mortalidad y de los Registros de Cáncer de Base Poblacional. Fueron estimados los nuevos casos y sus respectivas tasas de incidencia mediante los modelos de predicción tiempo-lineal o por la razón de incidencia y mortalidad. Resultados: Se prevén 704 mil nuevos casos de cáncer para el trienio 2023-2025. Exceptuando el cáncer de piel no-melanoma, ocurrirán 483 mil nuevos casos. El cáncer de mama femenino y el de próstata fueron los que tuvieron mayor incidencia con 73 mil y 71 mil nuevos casos, respectivamente. Les siguen el cáncer de colon y recto (45 mil), pulmón (32 mil), estómago (21 mil) y el cáncer del cuello uterino (17 mil). Conclusión: En el Brasil, por sus dimensiones continentales y heterogeneidad, en términos de territorio y población, el perfil de la incidencia refleja la diversidad de las regiones geográficas, coexistiendo estándares similares al de los países desarrollados y en vías de desarrollo.Introdução: O câncer é um problema de saúde pública mundial. Na última década, houve um aumento de 20% na incidência e espera-se que, para 2030, ocorram mais de 25 milhões de casos novos. Estimativas do número de casos novos de câncer são uma ferramenta poderosa para fundamentar políticas públicas e alocação racional de recursos para o combate ao câncer. A vigilância do câncer é um elemento crucial para planejamento, monitoramento e avaliação das ações de controle do câncer. Objetivo: Estimar e descrever a incidência de câncer no país, Regiões geográficas, Unidades da Federação, Distrito Federal e capitais, por sexo, para o triênio 2023-2025. Método: As informações foram extraídas do Sistema de Informação sobre Mortalidade e dos Registros de Câncer de Base Populacional. Foram estimados os casos novos e suas respectivas taxas de incidência pelos modelos de predição tempo-linear ou pela razão de incidência e mortalidade. Resultados: São esperados 704 mil casos novos de câncer para o triênio 2023-2025. Excetuando o câncer de pele não melanoma, ocorrerão 483 mil casos novos. O câncer de mama feminina e o de próstata foram os mais incidentes com 73 mil e 71 mil casos novos, respectivamente. Em seguida, o câncer de cólon e reto (45 mil), pulmão (32 mil), estômago (21 mil) e o câncer do colo do útero (17 mil). Conclusão: No Brasil, por suas dimensões continentais e heterogeneidade, em termos de território e população, o perfil da incidência reflete a diversidade das Regiões geográficas, coexistindo padrões semelhantes ao de países desenvolvidos e em desenvolvimento.INCA2023-02-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/370010.32635/2176-9745.RBC.2023v69n1.3700Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-213700Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-213700Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-2137002176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporengspahttps://rbc.inca.gov.br/index.php/revista/article/view/3700/2644https://rbc.inca.gov.br/index.php/revista/article/view/3700/2697https://rbc.inca.gov.br/index.php/revista/article/view/3700/2912https://rbc.inca.gov.br/index.php/revista/article/view/3700/2681Copyright (c) 2023 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Marceli de OliveiraLima, Fernanda Cristina da Silva deMartins, Luís Felipe LeiteOliveira, Julio Fernando PintoAlmeida , Liz Maria deCancela, Marianna de Camargo2023-06-01T17:29:02Zoai:rbc.inca.gov.br:article/3700Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-06-01T17:29:02Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Estimated Cancer Incidence in Brazil, 2023-2025 Incidencia Estimada de Cáncer en Brasil, 2023-2025 Estimativa de Incidência de Câncer no Brasil, 2023-2025 |
title |
Estimated Cancer Incidence in Brazil, 2023-2025 |
spellingShingle |
Estimated Cancer Incidence in Brazil, 2023-2025 Santos, Marceli de Oliveira neoplasias/epidemiologia neoplasias/mortalidade incidência estatística Brasil neoplasms/epidemiology neoplasms/mortality incidence statistics Brazil neoplasias/epidemiología neoplasias/mortalidad incidencia estadística Brasil |
title_short |
Estimated Cancer Incidence in Brazil, 2023-2025 |
title_full |
Estimated Cancer Incidence in Brazil, 2023-2025 |
title_fullStr |
Estimated Cancer Incidence in Brazil, 2023-2025 |
title_full_unstemmed |
Estimated Cancer Incidence in Brazil, 2023-2025 |
title_sort |
Estimated Cancer Incidence in Brazil, 2023-2025 |
author |
Santos, Marceli de Oliveira |
author_facet |
Santos, Marceli de Oliveira Lima, Fernanda Cristina da Silva de Martins, Luís Felipe Leite Oliveira, Julio Fernando Pinto Almeida , Liz Maria de Cancela, Marianna de Camargo |
author_role |
author |
author2 |
Lima, Fernanda Cristina da Silva de Martins, Luís Felipe Leite Oliveira, Julio Fernando Pinto Almeida , Liz Maria de Cancela, Marianna de Camargo |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Santos, Marceli de Oliveira Lima, Fernanda Cristina da Silva de Martins, Luís Felipe Leite Oliveira, Julio Fernando Pinto Almeida , Liz Maria de Cancela, Marianna de Camargo |
dc.subject.por.fl_str_mv |
neoplasias/epidemiologia neoplasias/mortalidade incidência estatística Brasil neoplasms/epidemiology neoplasms/mortality incidence statistics Brazil neoplasias/epidemiología neoplasias/mortalidad incidencia estadística Brasil |
topic |
neoplasias/epidemiologia neoplasias/mortalidade incidência estatística Brasil neoplasms/epidemiology neoplasms/mortality incidence statistics Brazil neoplasias/epidemiología neoplasias/mortalidad incidencia estadística Brasil |
description |
Introduction: Cancer is a worldwide public health problem, in the last decade there was an increase of 20% of the incidence and more than 25 million new cases are expected by 2030. Estimates of the number of new cancer cases are a powerful tool to support public policies and rational allocation of resources to fight cancer. Cancer surveillance is paramount for planning, monitoring and evaluating cancer control programs. Objective: To estimate and to describe the incidence of cancer in the country, geographic regions, states, Federal District and capitals, by sex, for the 2023-2025 period. Method: Cancer mortality and incidence information were extracted from the Mortality Information System and from Population-Based Cancer Registries. The number of new cases and their respective incidence rates were estimated by time-linear prediction models or by the incidence and mortality ratio. Results: 704,000 new cases of cancer are expected for the triennium 2023-2025. Except for nonmelanoma skin cancer, 483,000 new cases will occur. Female breast cancer and prostate cancer were the most frequent with 73,000 and 71,000 new cases, respectively, followed by colorectal cancer (45,000), lung (32,000) and stomach (21,000), and cervical cancer (17,000). Conclusion: In Brazil, due to its continental dimensions and heterogeneity both in terms of population and territory, the incidence profile reflects the diversity of geographic regions, and patterns similar to developed and developing countries. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-02-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3700 10.32635/2176-9745.RBC.2023v69n1.3700 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/3700 |
identifier_str_mv |
10.32635/2176-9745.RBC.2023v69n1.3700 |
dc.language.iso.fl_str_mv |
por eng spa |
language |
por eng spa |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3700/2644 https://rbc.inca.gov.br/index.php/revista/article/view/3700/2697 https://rbc.inca.gov.br/index.php/revista/article/view/3700/2912 https://rbc.inca.gov.br/index.php/revista/article/view/3700/2681 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Revista Brasileira de Cancerologia https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Revista Brasileira de Cancerologia https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf text/html |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-213700 Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-213700 Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-213700 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042238044241920 |